Matches in Wikidata for { <http://www.wikidata.org/entity/Q97047155> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q97047155 description "clinical trial" @default.
- Q97047155 description "ensayo clínico" @default.
- Q97047155 description "ensayu clínicu" @default.
- Q97047155 description "klinisch onderzoek" @default.
- Q97047155 description "клінічне випробування" @default.
- Q97047155 description "临床试验" @default.
- Q97047155 name "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 name "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 type Item @default.
- Q97047155 label "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 label "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 prefLabel "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 prefLabel "Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany" @default.
- Q97047155 P1050 Q97047155-363FEAA0-8927-4665-A052-54FA79CFE082 @default.
- Q97047155 P1132 Q97047155-1B1EE69B-0913-4479-AD64-CA1554D0A64E @default.
- Q97047155 P1476 Q97047155-903BEA0D-D55E-46FC-A211-992EFCE36487 @default.
- Q97047155 P2899 Q97047155-42F2BBEF-4195-45A8-BB1A-25275685B076 @default.
- Q97047155 P3098 Q97047155-3AB9C4A3-20E5-451A-9A86-50155862C368 @default.
- Q97047155 P31 Q97047155-56B62895-4ADB-4597-81C2-F13E49BF8764 @default.
- Q97047155 P4844 Q97047155-513040E3-BBBC-42BE-A2F3-9B3E154FB8DF @default.
- Q97047155 P580 Q97047155-6C6653B4-DB6A-4970-9316-476233FC052F @default.
- Q97047155 P582 Q97047155-BE187CCE-6834-4E97-8DA8-677504EA7EC9 @default.
- Q97047155 P8005 Q97047155-4531D4E2-9899-4FDA-AB86-BBDB7CC60D09 @default.
- Q97047155 P8363 Q97047155-8D680496-184C-48D8-BFB2-0DA26B80188B @default.
- Q97047155 P859 Q97047155-8029F060-122F-4AC1-A3D8-DCEB82E05F13 @default.
- Q97047155 P1050 Q9397786 @default.
- Q97047155 P1132 "+18000" @default.
- Q97047155 P1476 "Real-world Comparative Effectiveness of Rivaroxaban Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism (RECENT)" @default.
- Q97047155 P2899 "+18" @default.
- Q97047155 P3098 "NCT04444804" @default.
- Q97047155 P31 Q30612 @default.
- Q97047155 P4844 Q267896 @default.
- Q97047155 P580 "2020-07-01T00:00:00Z" @default.
- Q97047155 P582 "2020-11-30T00:00:00Z" @default.
- Q97047155 P8005 Q76649614 @default.
- Q97047155 P8363 Q818574 @default.
- Q97047155 P859 Q152051 @default.